Bcl-2 has been reported to play an important role in paclitaxel-mediated apoptosis and anti-tumor pathway [25, 26], therefore, it is an important effector protein in paclitaxel-mediated tumor chemotherapy. This evidence concerns the gene BCL2 and neoplasm.